Company Filing History:
Years Active: 2019
Title: Tanja Lange: Innovator in Antibody Development
Introduction
Tanja Lange is a prominent inventor based in Germering, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. Her work focuses on addressing medical challenges associated with specific receptor expressions.
Latest Patents
Tanja Lange holds a patent for a human anti-FGFR4 antibody. This invention relates to innovative antibodies targeting the FGF receptor 4 (FGFR4). The medical applications of this patent are crucial for the diagnosis, prevention, or treatment of diseases linked to FGFR expression, overexpression, or hyperactivity.
Career Highlights
Throughout her career, Tanja Lange has worked with notable companies, including Daiichi Sankyo Europe GmbH and Daiichi Sankyo Company, Limited. Her expertise in antibody development has positioned her as a key player in the biotechnology sector.
Collaborations
Tanja has collaborated with esteemed colleagues such as Reimar Abraham and Keisuke Fukuchi. These partnerships have further enhanced her research and development efforts in the field.
Conclusion
Tanja Lange's contributions to antibody research and her innovative patent highlight her role as a leading inventor in biotechnology. Her work continues to pave the way for advancements in medical treatments.